IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-031-30203-9_31.html
   My bibliography  Save this book chapter

VP of BioCubaFarma Discuss Partnerships, COVID-19, and the Future of the Company—Dr. Mayda Mauri Pérez

In: The Cuba Interviews

Author

Listed:
  • T. K. Hernández

Abstract

Part VIII explores Cuba’s priority sectors: health, medical tourism, and biopharmaceuticals. It provides industry insights from doctors, executives, and an editor of a peer-reviewed medical journal. These interviews highlight the successes of the healthcare system, research and collaboration, investments, pharmaceuticals, vaccine development, joint ventures, and medical tourism. This chapter is a conversation held with Dr. Mayda Mauri Pérez, Vice President of BioCubaFarma. Dr. Mauri has worked in the biotech sector for over 27 years. In 2012, she was one of the founding members of the BioCubaFarma business group. The company oversees 32 research and development, pharmaceutical manufacturing, and medical equipment businesses, exporting products to over 40 countries. This interview took place in July 2020 during the pandemic lockdowns. The focus is BioCubaFarma’s international collaborations, the clinical trials of CIMAvax-EGF in U.S. cancer patients at the Roswell Park Cancer Center, and those with China and Russia. Dr. Mauri discusses the future direction of BioCubaFarma, its product portfolio, challenges and successes during the pandemic, and COVID-19 drug trials. She also speaks of the potential for international investor partnerships, especially those found in the biopharmaceutical hub in the Mariel Special Development Zone (ZEDM).

Suggested Citation

  • T. K. Hernández, 2023. "VP of BioCubaFarma Discuss Partnerships, COVID-19, and the Future of the Company—Dr. Mayda Mauri Pérez," Springer Books, in: The Cuba Interviews, chapter 0, pages 311-319, Springer.
    • Handle: RePEc:spr:sprchp:978-3-031-30203-9_31
    DOI: 10.1007/978-3-031-30203-9_31
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-031-30203-9_31. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.